Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis
Experimental Dermatology · 2024
DOI: 10.1111/exd.14973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Torsa Ganguly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics Unit, Indian Statistical Institute, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: MicroRNAs, Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Psoriasis vulgaris is a chronic, autoimmune skin disease involving a complex interplay of epidermal keratinocytes, dermal fibroblast and infiltrating immune cells. Differential expressions of miRNAs are observed in psoriasis and the deregulated miRNAs are sometimes associated with disease severity. This study aims to identify miRNAs altered in the serum of psoriasis patients that are associated with the Psoriasis Area and Severity Index (PASI). In order to assess miRNA levels in the serum of psoriasis patients, we selected 24 differentially expressed miRNAs in the psoriatic skin are possibly derived from the skin and immune cells, as well as five miRNAs that are enriched in other tissues. We identified 16 miRNAs that exhibited significantly ( p < 0.05) altered levels in the serum of psoriasis patients compared to healthy individuals. Among these, 13 miRNAs showed similar expression pattern in the serum of psoriasis patients as also observed in the psoriatic skin tissues. Ten miRNAs showed an accuracy of greater than 75% in classifying the psoriasis patients from healthy individuals. Further analysis of differential miRNA levels between the low PASI group and the high PASI group identified three miRNAs (miR‐147b, miR‐3614‐5p, and miR‐125a‐5p) with significantly altered levels between the low severity and the high severity psoriasis patients. Our systematic investigation of skin and immune cell‐derived miRNAs in the serum of psoriasis patients revealed alteration in miRNA levels to be associated with disease severity, which may help in monitoring the disease progression and therapeutic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Genetics Unit, Indian Statistical Institute, Kolkata, West Bengal, India.
- Consultant Dermatologist, Uttarpara, West Bengal, India.
- Department of Dermatology, IPGMER/SSKM Hospital, Kolkata, West Bengal, India.
ORCID-Profile: Raghunath Chatterjee
Förderung
- Science and Engineering Research Board
Zitieren
APA
Ganguly, T., Laha, S., Senapati, S., Chatterjee, G., & Chatterjee, R. (2024). Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis. Experimental Dermatology. https://doi.org/10.1111/exd.14973
Vancouver
Ganguly T, Laha S, Senapati S, Chatterjee G, Chatterjee R. Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis. Experimental Dermatology. 2024. doi:10.1111/exd.14973
BibTeX
@article{Ganguly2024,
author = {Ganguly, Torsa and Laha, Sayantan and Senapati, Swapan and Chatterjee, Gobinda and Chatterjee, Raghunath},
title = {Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.14973}
}
EUVIMED